Vance JM, Farrer LA, Huang Y, Cruchaga C, Hyman BT, Pericak-Vance MA, Goate AM, Greicius MD, Griswold AJ, Haines JL, Tcw J, Schellenberg GD, Tsai LH, Herz J, Holtzman DM. Report of the APOE4 National Institute on Aging/Alzheimer Disease Sequencing Project Consortium Working Group: Reducing APOE4 in Carriers is a Therapeutic Goal for Alzheimer's Disease. Ann Neurol. 2024 Apr;95(4):625-634. Epub 2024 Jan 5 PubMed.
Recommends
Please login to recommend the paper.
This paper appears in the following:
Mutations
- APOE Loss of Function Variants
- APOE W5Ter
- APOE E27fs
- APOE G49fs
- APOE E98fs
- APOE E114fs
- APOE C130R (ApoE4)
- APOE R154S (Christchurch)
- APOE R154fs
- APOE A227_E230del
- APOE W228Ter
- APOE V254E
- APOE R269G
- APOE c.-286T>G (rs405509)
- APOE c.237-1A>G
- APOE Region
- APOE L8Ter
- APOE g.45408560_45410359del
- APOE Q39Ter
- APOE E84Ter
Comments
No Available Comments
Make a Comment
To make a comment you must login or register.